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Abstract: Objectives: To examine association of candidate genetic variants in structural, inflammatory, matrix modifying, 
vitamin D receptor genes and variants associated with osteoarthritis, with surgical candidates and surgical patients with 
lumbar disc degeneration (LDD), in light of their previously reported susceptibility for LDD. 
Methods: Genotyping of 146 Norwegian LDD patients and 188 Norwegian controls was performed for 20 single-
nucleotide polymorphisms (SNPs) from collagen, aggrecan, interleukin, VDR, MMP3 and COX2 genes and 7 SNPs from 
osteoarthritic genes. 
Results: The neighboring genes IL18R1 and IL18RAP polymorphisms (rs2287037 and rs1420100), showed a statistically 
non-significant risk for developing LDD (OR 1.36 [95 % CI 0.99 – 1.87]; p=0.06 and OR 1.33 [95 % CI 0.98-1.81]; 
p=0.07). Homozygosity of these risk alleles was associated with LDD (p=0.023 and p=0.027). The non-risk alleles at 
these SNPs were situated on a haplotype negatively associated with LDD (p=0.008). Carriage of at least one non-risk 
allele at both loci also reduces the risk of developing LDD (OR 0.51 [95 % CI 0.33-0.80]; p=0.003). 
Conclusion: Our findings support the polygenic nature of LDD and suggest that variation in interleukin 18 receptor genes 
could affect the risk of severe LDD and associated low back pain. 
Keywords: Candidate genes, interleukin 18 receptor 1, interleukin 18 receptor accessory protein, low back pain, lumbar disc 
degeneration, Single-nucleotide polymorphisms. 
INTRODUCTION 
  About three quarters of the population of the industria-
lized western world, occasionally experience low back pain 
(LBP) in their lifetime, which is one of the commonest 
causes of activity limitation among the younger age group 
[1]. Apart from the distress and disability incurred to the 
patient, it also takes a heavy toll upon the socioeconomic 
aspect of the society [2]. Its prevalence in Norway has been 
estimated to be 53 % [3]. Lumbar disc degeneration (LDD) 
is believed to represent a major cause of LBP [4, 5], but a 
comprehensive definition and insight into its etiology and 
pathogenesis are still lacking. 
  Progressive structural failure can trigger an aberrant 
response of the disc cells, leading to degeneration of the disc 
[6]. A series of cellular and morphological age related 
changes occurs in the discs over time [7]. The prevalence of 
LDD is about 40 % under 30 years and over 90 % in the fifth 
decade of life [8]. A degenerated disc causing pain is labeled 
as degenerative disc disease [6] and not all radiologically 
assessed changes cause pain [9]. 
  Until the beginning of the nineties, etiology was attribu-
ted mainly to the environmental influences on the normally 
aging disc, such as occupational or leisure time physical 
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loading, postural stresses, vibration, injury, driving and 
smoking [10-14]. Later, twin studies established a strong 
familial predisposition and emphasis was laid on major 
contribution from genetic factors [15-18]. It is quite likely 
that the LDD has a multifactorial pathogenesis, also 
involving gene environment interactions [19]. 
  Genes related to the molecular components of the disc 
and associated biochemical pathways have been explored as 
candidate genes for LDD. The extracellular matrix of 
aggrecan containing gelatinous nucleus and fibro cartilagi-
nous annulus fibrosus is mainly composed of Collagen I and 
II, with Collagen I predominantly in the annulus and 
Collagen II in nucleus. Collagens V, VI, IX, XI, XII and 
XIV also contribute to the matrix though scarcely [20]. Disc 
degeneration involves dehydration due to fragmentation and 
eventual loss of aggrecan from the nucleus, causing it to 
behave non-hydrostatically under load [21]. This leads to 
disc height reduction and eventually osteoarthritis of 
apophyseal joints. Aggrecan, also prevents large pro 
inflammatory molecules from entering into the matrix [22] 
and with its loss, there is an increased inflow of such 
molecules which can cause degeneration by enzymatic break 
down and local inflammation [23]. Associated pain can 
occur due to sensitization of nerve root by these inflam-
matory molecules secreted by the cells of a degenerated, 
herniated disc such as prostaglandin E2, phospholipase A2, 
MMPs, TNF- and interleukins [24, 25]. 
  Hence all genes coding for the structural proteins of a 
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degradation are ideal candidates to be analyzed for exploring 
the role of genetics in disc degeneration. So far significant 
associations for the polymorphisms of aggrecan (AGC), 
collagens (COL1A1, COL9A1, COL9A2, COL9A3, 
COL11A1, COL11A2), vitamin D receptor (VDR), matrix 
metalloproteinases (MMP2, MMP3, MMP9), interleukins 
(IL1, IL2, IL18R1, IL18RAP), cyclooxygenase-2 (COX2) 
and cartilage intermediate layer protein (CILP) have been 
reported with different pathologic changes of disc degenerat-
ion and clinical phenotypes [26-44]. To our knowledge, the 
association of these gene candidates has never been tested in 
a Norwegian LDD cohort. 
  Osteoarthritis in general, is another morbid condition that 
has similarities in clinical phenotypes with LDD [45] which 
involves OA of facet joints. Genes coding for frizzled-
related protein (FZRP), calmodulin (CALM1), growth and 
differentiation factor 5 (GDF5), prostaglandin-endoper-
oxidase synthase-2 (PTGS2) and double von willebrand 
factor A domains (DVWA) have been observed to be 
associated with osteoarthritis but have not been studied in 
LDD [46-49]. 
  The aims of this study were to examine the allelic 
diversity of structural, inflammatory, matrix modifying, 
vitamin D receptor gene variants and variants previously 
associated with osteoarthritis and their association with 
surgical candidates and surgical patients with LDD. 
SUBJECTS AND METHODS 
Cases and Controls 
  This study included 146 unrelated Norwegian patients, 
with chronic low back pain and disc degeneration. The age 
of the patients ranged from 30 to 76 years (mean = 53.2 
years). Among whom, 80 were females and 66 were males 
and their age at the first time experience of back pain ranged 
from 10 to 61 years (mean [SD], 32.9 [10.3]). Patients were 
recruited from two randomized controlled trials (RCTs) [50, 
51], a pilot study [52] and had been evaluated to have LBP, 
disc degeneration and as candidates for surgery at least 8-9 
years ago. Patients had to have pain duration for at least 1 
year and degeneration at L4-L5 or L5-S1, as evaluated by 
plain radiography and either computed tomography or 
magnetic resonance imaging. Among them 27 were treated 
conservatively, 73 had lumbar fusion and 46 underwent 
discectomy (Table 1). The control group comprised of 188 
healthy Norwegian individuals from the Norwegian Bone 
Marrow Donor Registry with an unknown history of back 
pain and age ranging from 24 to 56 years (mean = 39.3 
years). Half of the controls were males and half females. 
Patients were asked about ethnicity, age of onset, duration of 
pain, family history of back pain, and smoking through a 
standard questionnaire. Patients were asked if they were 
smoking at inclusion and the number of cigarettes they 
smoked per day. 141 patients had one or more first degree 
relatives with back pain but 5 patients did not have any 
known family members with back pain history. All subjects 
received detailed written information about the study 
procedures and provided informed consent before their 
participation. The study was approved by the Regional 
Committee for Medical Research Ethics in Health Region 
South-East Norway. 
Selection of Candidate Gene SNPs 
  A total of 27 single-nucleotide polymorphisms (SNPs) 
from 20 different candidate genes were tested (Table 2). 20 
SNPs from 14 genes with a biologic relevance for disc 
structure, biochemistry and mechanics were selected for 
genotyping, based upon previously reported association with 
LDD in different study populations. Variants that have 
previously shown significant associations with different 
LDD phenotypes were focused. Variants of some genes that 
had not been found to be significantly associated, but were 
biologically relevant were also included. Altogether SNPs 
from collagen genes (COL1A1, COL2A1, COL3A1, 
COL9A1, COL9A2, COL9A3, COL11A1 and COL11A2), 
aggrecan gene (AGC1), vitamin D receptor gene (VDR), 
interleukin genes (IL1A, IL18R1, and IL18RAP), matrix 
metalloproteinase-3 gene (MMP3), and cyclooxygenase-2 
gene (COX2). Furthermore, seven SNPs from six genes 
(PTGS2, CALM1, FZRP, DVWA and GDF5) were tested on 
the basis of their association reported with osteoarthritis, due 
to its clinical similarities to our phenotype of interest. 
Genotyping 
  Genomic DNA from 140 patients, was extracted 
manually from 9 ml of peripheral blood leucocytes by the 
salting out method [53] and from the remaining 6 patients, 
the DNA was extracted manually from 4 ml of saliva sample 
using the collection kit (DNA Genotek, Kanata, Ontario, 
Canada) following the protocol by the manufacturer. DNA 
Table  1.  Demographic and Disease Characteristics Cases with Chronic Low Back Pain Given as Numbers N, Unless Stated 
Otherwise 
 
Total number of cases  146 patients with lumbar disc degeneration 
Ethnicity  Norwegian 
Gender (Males/Females)  68/78 
Age (8 year follow up), years  Range: 30-76, Mean [SD]: 53.2 [8.8] 
Age of Onset, years  Range: 10-61, Mean [SD]: 32.9 [10.3]  
Duration of pain (baseline), months  Range: 10-480, Mean [SD]: 128.8 [103.04] 
Smokers/non-smokers/unknown 68/69/9 
Surgical status (None/discectomy/lumbar fusion)  27/46/73 
History of back pain in first degree relatives, with no treatment/conservative treatment/surgery/unknown  19/82/40/5 166    The Open Orthopaedics Journal, 2012, Volume 6  Omair et al. 
quality and quantity were measured on a DNA 
spectrophotometer (ND-1000, NanoDrop, Wilmington 
USA). All the DNA samples were of good quality and 
quantity and had ratios within 1.8-2.0 at A260/280 and 
within 1.8-2.2 at A260/230. DNA from the controls was 
available before hand. Genotyping was performed using a 
Autoflex instrument and iplex kits from Sequenom
TM 
(Hamburg, Germany), at the Centre for interactive genetics; 
Cigene, Norwegian University of Life Sciences (UMB) Aas. 
20 ng DNA was used and one negative control (water) was 
included with every 95 samples with variable positions, so 
that it served both as technical and positional control. Real-
time genotype calling was followed by manual inspection 
and where necessary adjustment. 
Statistical Analysis 
  Genotype success rate, Hardy-Weinberg equilibrium 
(HWE), linkage disequilibrium and allelic associations were 
calculated using Haploview version 4.2 [54]. Unphased 
version 3.0.7 [55] was used to estimate haplotypes by the 
expectation-maximization algorithm and to test for 
association, as well as to calculate linkage disequilibrium. In 
accordance with the approach of this statistical programme 
for haplotype analysis, one allele was compared to a 
reference haplotype. Odds ratio (OR) with 95  % CI was 
calculated with respect to minor allele compared to major 
allele, using the Haldanes modification of Woolf’s method 
[56, 57]. P-value threshold of  0.05 was chosen based upon 
the fact that it was a replication study of variants already 
reported to be significantly associated with LDD. At this 
threshold value, we had 80 % power to detect a genotype 
effect of frequency = 0.3 with an OR > 1.9 and an allele 
effect of frequency = 0.4 with an OR > 1.5. Power 
calculations were done in PS Power and Sample Size 
Calculations Version 3.0. The p-value threshold after 
Bonferroni correction for multiple testing was calculated to 
be 0.0019, as we tested 27 SNPs (0.05/27). 
Table 2.  Selected SNP Candidates for Lumbar Disc Degeneration 
 
Gene SNP*  Chromosome  Location  Minor/Major  Allele  References 
AGC1  rs1042631 15q26.1  Exon  (L2141L)  T/C [26] 
AGC1 rs1516797  15q26.1  Intron  G/T  [26] 
VDR  rs10735810  12q13.11  Exon (M162T)  C/T  [37] [70] 
VDR  rs731236  12q13.11  Exon (I352I)  C/T  [37] [70] 
COL1A1  rs2075555 17q21.33  Intron  A/C  [26]  [29] 
COL2A1  rs917055 12q13.11  Intron  T/C  [26] 
COL3A1  rs2056156 2q32.2  Intron  C/T  [26] 
COL9A1  rs696990 6q13 Intergenic G/A  [26] 
COL9A2  rs7533552  1p34.2  Exon (Q326R)  G/A  [26] [30] [31] 
COL9A3  rs61734651  20q13.33  Exon (R103W)  C/T  [32] [33] 
COL11A1  rs1463035 1p21.1  Intron  G/A  [26]   
COL11A1  rs1676486 1p21.1  Exon  (S1535P)  A/G  [34] 
COL11A2  rs2072915 6p21.32 Upstream  T/A  [26] 
IL1A  rs2071375 2q13  Intron  A/G  [26]  [42] 
IL18R1  rs2287037 2q12.1 Upstream  A/G  [26] 
IL18RAP  rs1420100 2q12.1  Intron  T/G  [26] 
IL18RAP  rs1420106 2q12.1 Upstream  T/C  [26] 
IL18RAP  rs917997 2q12.1  Downstream A/G  [26] 
MMP3  rs72520913 11q22.2  Upstream  -/A  [38] 
COX2(PTGS2)  rs5277 1q31.1  Exon  (V102V)  C/G  [43] 
PTGS2(COX2)  rs4140564 1q31.1 Upstream  C/T  [49] 
CALM1  rs12885713 14q32.11  5’UTR  C/T  [47] 
DVWA  rs11718863 3p25.1  Exon  T/A  [48] 
DVWA  rs7639618 3p25.1  Exon  T/C  [48] 
FZRP  rs288326 2q32.1  Exon  (R200W)  A/G  [46] 
FZRP  rs7775 2q32.1  Exon  (R324G)  G/C  [46] 
GDF5  rs143383 20q11.22  5’UTR  C/T  [48] 
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RESULTS 
The Risk of LDD is Associated with IL18R1 and 
IL18RAP on Chromosome 2q12 
  The genotype success rate of the 27 candidate SNPs was 
 95 % with a mean success rate of 99.2 %. None of the 
selected SNPs was excluded due to technical problems with 
genotyping, and no divergence from Hardy-Weinberg 
equilibrium was observed for any of the markers (p  0.001). 
Allele frequencies of the 27 SNPs in both cases and controls 
are given in Table 3. Two polymorphisms, rs2287037 from 
Interleukin 18 receptor 1 (IL18R1) gene and rs1420100 from 
Interleukin 18 receptor accessory protein (IL18RAP) gene 
showed a statistically non-significant association (p=0.06 
and p=0.07). Both these SNPs were in HWE (p values for 
rs2287037 and rs1420100 were 0.51 and 0.81 respectively). 
Compared to the controls, there was a non-significant 
increase in risk of LDD for both IL18R1 (OR 1.36, 95 % CI 
0.99 – 1.87) and IL18RAP (OR 1.33 95 % CI 0.98-1.81). 
  The CC genotype at IL18R1 polymorphism (rs2287037) 
was associated (p=0.023) with LDD and was more frequent 
among cases (45.2%) compared to controls (33.0 %). For 
IL18RAP, an association was observed for the AA genotype 
at rs1420100 (p= 0.027). Both polymorphisms followed a 
recessive disease model with a risk for LDD in cases which 
were homozygous for risk allele (OR 1.67 [95 % CI 1.07-
2.60] and OR 1.83 [95% CI 1.07-3.14], respectively). 
  Our associations were not statistically significant after 
Bonferroni correction. 
  Conversely the other alleles at these SNPs were 
negatively associated with LDD, and interestingly they were 
Table  3.  Association Analysis of the Structural, Inflammatory, Matrix Degradative, Vitamin D Receptor and Osteoarthritis 
Associated Gene Variants with LDD 
 
 SNP***   Gene  Risk Allele  RAF** Cases  RAF Control   OR*(95% CI)  p Value 
rs1042631  AGC1  T 0.212  0.176  1.27  (0.86-1.86)  0.23 
rs1516797  AGC1  T 0.641  0.622  1.09  (0.79-1.50)  0.60 
rs10735810  VDR  A 0.401  0.370  1.14  (0.83-1.56)  0.41 
rs731236  VDR  A 0.603  0.568  1.16  (0.85-1.58)  0.35 
rs2075555  COL1A1  G 0.873  0.864  1.08  (0.69-1.70)  0.74 
rs917055  COL2A1  A 0.168  0.168  1.00  (0.67-1.51)  0.99 
rs2056156  COL3A1  C 0.441  0.420  1.09  (0.80-1.48)  0.58 
rs696990  COL9A1  C 0.210  0.173  1.27  (0.86-1.87)  0.22 
rs7533552  COL9A2  T 0.757  0.731  1.14  (0.80-1.63)  0.45 
rs61734651  COL9A3  C 0.942  0.939  1.05  (0.56-1.97)  0.87 
rs1463035  COL11A1  T 0.810  0.797  1.08  (0.74-1.59)  0.68 
rs1676486  COL11A1  A 0.229  0.217  1.07  (0.74-1.55)  0.72 
rs2072915  COL11A2  T 0.731  0.714  1.09  (0.77-1.54)  0.62 
rs2071375  IL1A  C 0.700  0.670  1.15  (0.82-1.60)  0.42 
rs2287037  IL18R1  C 0.668  0.596  1.36  (0.99-1.87)  0.06 
rs1420100  IL18RAP  A 0.493  0.422  1.33  (0.98-1.81)  0.07 
rs1420106  1L18RAP  A 0.253  0.239  1.08  (0.76-1.54)  0.68 
rs917997  IL18RAP  T 0.262  0.235  1.16  (0.81-1.65)  0.43 
rs72520913  MMP3  A 0.497  0.470  1.11  (0.82-1.51)  0.50 
rs5277  COX2(PTGS2)  C 0.836  0.832  1.02  (0.68-1.54)  0.91 
rs4140564  PTGS2(COX2)  A 0.949  0.931  1.35  (0.72-2.56)  0.34 
rs12885713  CALM1  C 0.451  0.406  1.20  (0.88-1.64)  0.25 
rs11718863  DVWA  A 0.842  0.824  1.14  (0.76-1.71)  0.54 
rs7639618  DVWA  C 0.842  0.824  1.14  (0.76-1.71)  0.54 
rs288326  FZRP  A 0.123  0.109  1.15  (0.72-1.84)  0.57 
rs7775  FZRP  C 0.083  0.059  1.42  (0.79-2.56)  0.24 
rs143383  GDF5  A 0.651  0.629  1.10  (0.79-1.52)  0.57 
*Odds ratio (95 % Confidence interval); ** Risk allele frequency; *** Single-nucleotide polymorphism. 
§rs2287037, allele counts in cases: 66 CC, 63 CT, 17 TT; allele counts in controls: 62 CC, 100 CT and 26 TT. 
rs1420100, allele counts in cases: 37 AA, 69 AC, 39 CC; allele counts in controls: 29 AA, 98 AC and 58 CC. 168    The Open Orthopaedics Journal, 2012, Volume 6  Omair et al. 
situated on a haplotype rs2287037*T-rs1420100*C that were 
less frequent in cases compared to controls (23.7 % vs 34.3 
%, p=0.008; Table 4). The linkage disequilibrium between 
these two alleles was modest; D'<0.65 and r
2<0.2. Hence, 
since carriage of non-risk allele seemed to protect against 
development of LDD at both loci, we tested the distribution 
of simultaneously carrying at least one non-risk allele at both 
loci and found it to reduce the risk of developing LDD (OR 
0.51 [95 % CI 0.33-0.80]; p= 0.003). 
Table  4.  Association Analysis of Estimated Haplotypes of 
IL18R1 (rs2287037) and IL18RAP (rs1420100) 
 
Haplotype  Cases 
n (%)  
Controls 
n (%) 
OR**  
(95 % CI) 
p  
Value 
 T - C  68.8 (23.7)  126.9 (34.3)   0.63 (0.43-0.93)  0.008 
 C – A*  114.8 (39.6)  133.9 (36.2)  1.0 0.176 
 C - C  78.2 (27.0)  87.1 (23.5)  1.05 (0.68-1.61)  0.563 
 T - A  28.2 (9.7)  22.1 (6.0)  1.49 (0.71-3.10)  0.225 
*Reference haplotype; ** Odds ratio (95 % Confidence interval). 
 
Association of IL18RAP-IL18R1 in Non-Smokers 
  Smoking is an environmental factor that has been shown 
to influence the risk of LDD according to some studies [58]. 
The frequency of the protective haplotype, rs2287037*T-
rs1420100*C was lowest among the non-smoking patients 
(19.6 %) compared to LDD smokers (28.5 %) and controls 
(34.3 %). Hence the haplotype only conferred a reduced risk 
of LDD among non-smoking patients compared to controls 
(p=0.007). Cases were considered as smokers if they were 
smoking at inclusion. Unfortunately, smoking status was not 
available among controls. Significance was not reached 
when smokers were compared with non-smokers among 
LDD patients only (p=0.2). 
DISCUSSION 
 Alleles at IL18RAP (rs1420100) and IL18R1 
(rs2287037) SNPs did not show a statistically significant 
association individually, but the tendency of association for 
IL18R1 (rs2287037) showed a similar trend as in a previous 
study (p = 0.054) by Videman et al. [26]. Homozygosity of 
risk alleles was associated with the risk of LDD. The non-
risk alleles of two polymorphisms were negatively 
associated with LDD when looking at them together on a 
haplotype. This haplotype association might be in linkage 
disequilibrium with a locus involved in predisposition to 
LDD or it might mark several risk polymorphisms, either 
including or excluding those tested here in this interleukin 
gene cluster on chromosome 2q12. 
  In accordance with our findings, a study of 588 
monozygotic and dizygotic male twins from the Finish 
population, has shown association of IL18RAP (rs1420100) 
with disc desiccation but not with disc height narrowing or 
bulging [26]. Videman et al. observed an association 
between individuals with AC genotype and a higher disc 
signal intensity, and a nearly identical association of AA and 
CC alleles with a lower disc signal intensity (personal 
communication), while we found the CC genotype to 
predispose to LDD. We observed haplotypic association for 
across IL18R1 and IL18RAP for rs2287037*T-
rs1420100*C. As for many complex disorders, inter study 
heterogeneity also exists for LDD [59], particularly since the 
markers tested in studies are likely to be secondary to the 
causal variants and therefore inter-population differences in 
LD patterns will influence the single SNP association 
outcome. Videman et al. also found another polymorphism 
of the IL18RAP (rs917997) to be associated with disc 
desiccation, but no association was observed for this 
polymorphism in our sample. They found rs917997 to be 
tagging with the haplotype of IL1RL1, IL18R1, IL18RAP, 
and SLC9A4. This gene cluster has been shown to be 
associated with other inflammatory disorders, like 
inflammatory bowel disease [60], coeliac disease [61] and 
asthma. Our findings suggest that inflammation also play a 
role in patients with chronic LBP and disc degeneration. 
  IL18RAP is a subunit of IL18 receptor along with 
IL18R1 [62] and is essential for IL18 signal transduction and 
ligand binding affinity to IL18R and hence plays a 
functional role of regulation of both innate and adaptive 
immunity [63]. Activation of T cells and natural killer cells 
results in secretion of interferon gamma (IFN-), which in 
turn activates macrophages that secrete cytokines TNF- and 
IL1, which are involved in increased matrix degradation both 
directly and through activation of proteinases and have been 
found to be secreted by the cells of a degenerated and 
herniated disc [23, 24, 64]. We speculate that 
polymorphisms of IL18RAP and IL18R1 might play a role 
by triggering an inflammatory response through one of the 
above mentioned mechanisms and hence shed light on the 
role of inflammation in LDD and a possible pathway for 
associated back pain [24]. While the presence of disc 
degeneration in many asymptomatic individual indicates an 
unclear relationship with back pain [65], high levels of 
cytokines like TNF- have been found in degenerated discs 
where the nerve ending is exposed to enzymes and 
inflammatory mediators, which may explain pain in 
discogenic patients [66]. 
  The polymorphism of IL18R1 (rs2287037) has 
previously also showed a tendency towards association with 
disc desiccation (p=0.054) in the study by Videman et al. 
[26]. Videman et al. observed an association between 
individuals with CC alleles and lowest disc signal intensity 
and TT alleles were found to be associated with higher disc 
signal intensity (personal communication). Our results 
support these finding of Videman et al. as in the current 
study the cases with CC alleles were found to be associated 
with LDD. To our knowledge, this is only the second time 
that a similar trend in association of IL18R1 polymorphism 
rs2287037 with LDD has been reported. The IL18R1 gene, 
along with four other members of the interleukin 1 receptor 
family (IL1R2, IL1R1, ILRL2, and IL1RL1) form a gene 
cluster on chromosome 2q. IL1R1 has shown to be 
associated with hand OA [67] and a genome wide linkage 
study have found a region of interest that could harbor genes 
for both LDD and OA [68]. Over expression of IL18 and 
IL18R has also been proposed to play a role in pathogenesis 
of rheumatoid arthritis [69]. 
  We cannot exclude that our results could be false positive 
because of a small sample size and the fact that our 
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multiple testing. On the other hand, the associations were 
with genetic variants already been reported to be associated 
with LDD. Hence in the future we intend to replicate our 
findings in a much larger European population evaluated for 
disc signal as well as advanced findings of LDD. 
  It is foremost to define a clear phenotype of disc 
degeneration [6] because this is a multi stage process 
progressing from decreased disc signal intensity (disc 
desiccation) to disc height narrowing, disc bulging, end plate 
degeneration and osteophytosis of facet joints [70]. Videman 
et al. showed association of IL18RAP and IL18R1 with an 
early stage of degeneration (disc desiccation). In contrast, 
our findings suggest associations in a patient population with 
severe chronic low back pain and disc degeneration, with 
majority had lumbar fusion and hence this group is 
considered to have advanced lumbar disc disease. 
  We however did not find any associations of other 
structural, matrix degrading, Vitamin D and osteoarthritic 
genes with advanced stage degeneration in our patients. 
Videman  et al. on the other hand did find 10 such 
associations but most of them with an early stage of 
degeneration (disc desiccation) [26]. Inability to detect any 
such associations in our study could be due to limitations of 
small sample size, not covering all variants of the candidate 
genes and lack of advanced imaging (no information on disc 
signal intensity and disc bulging). Videman et al. had an 
enhanced ability to detect the associations with an early stage 
LDD, due to an accurate method of quantitative 
measurement of degeneration using cerebrospinal fluid 
adjusted disc signal intensity, which we lacked and they 
studied 99 variants compared to 27 in our study. This 
reduced our power and precision to estimate the association. 
The DNA from control group had been collected previously, 
but was not linked to information about back pain and 
degeneration. Although they were considered healthy at 
inclusion, we would expect that some of them had disc 
degeneration and had experienced back pain. The association 
of IL18RAP-IL18R1 haplotype in non smokers could also be 
false positive due to a small sample, lack of information on 
smoking status of controls and that smokers among cases 
were smoking at inclusion. 
  The proportion of LDD and its associated LBP in patients 
was supposed to be higher than controls because they 
attended the orthopedic clinic and had either undergone or 
were candidates for surgery. We could have enhanced our 
power to detect association for other genes if we compared 
patients with controls without any degeneration, or even 
better if we have had access to a larger patient cohort. The 
study design of Videman et al, on the other hand, was not 
case-control based. Our study had genetic homogeneity (all 
subjects were of homogenous Norwegian origin) [71], a high 
genotype success rate (94.9 % to 100 %), no SNP was 
excluded due to technical issues with genotyping and there 
was no deviation of any SNP from Hardy Weinberg 
equilibrium. 
  Our study is supportive of a polygenic nature of lumbar 
disc degeneration and suggests that variation in interleukin 
18 receptor genes could affect the risk of advanced stage of 
disc degeneration and its associated LBP. Our findings need 
to be tested in a larger sample with an accurate phenotype 
classification. 
ABBREVIATIONS 
LDD  =  Lumbar disc degeneration 
LBP  =  Low back pain 
SNPs =  Single-nucleotide  polymorphisms 
IL18R1  =  Interleukin 18 receptor 1 
IL18RAP  =  Interleukin 18 receptor accessory protein. 
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